Evidence map›Paper›PMID 40872491›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Mizusa Hyodo, Kei Kawada, Tomoaki Ishida, Yuki Izawa-Ishizawa, Ryoko Matoba, Rina Okamoto, Kohei Jobu, Io Horikawa, Fuka Aizawa, Kenta Yagi and 6 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mizusa HyodoDepartment of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.ORCID 0009-0009-5600-7221
Kei KawadaDepartment of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.
Tomoaki IshidaDepartment of Clinical Pharmacy, Nagoya City University Graduate School of Pharmaceutical Sciences, 3-1, Tanabe-dori, Mizuho-ku, Nagoya 467-8603, Japan.
Yuki Izawa-IshizawaDepartment of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.ORCID 0000-0002-8178-9028
Ryoko MatobaDepartment of Clinical Pharmacy Practice Pedagogy, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.
Rina OkamotoDepartment of Clinical Pharmacy Practice Pedagogy, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.
Kohei JobuDepartment of Pharmacy, Kochi Medical School Hospital, 185-1 Okochokohasu, Nankoku 783-0043, Japan.ORCID 0000-0002-6755-4628
Io HorikawaDepartment of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.
Fuka AizawaDepartment of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.
Kenta YagiDepartment of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.
Takahiro NiimuraDepartment of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.ORCID 0000-0003-2033-4246
Yayoi KawanoDepartment of Clinical Pharmacy, Nagoya City University Graduate School of Pharmaceutical Sciences, 3-1, Tanabe-dori, Mizuho-ku, Nagoya 467-8603, Japan.
Shinji AbeDepartment of Clinical Pharmacy Practice Pedagogy, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.ORCID 0009-0007-1746-1777
Yukihiro HamadaDepartment of Pharmacy, Kochi Medical School Hospital, 185-1 Okochokohasu, Nankoku 783-0043, Japan.ORCID 0000-0002-5659-6507
Mitsuhiro GodaDepartment of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.
Keisuke IshizawaDepartment of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, 3-18-15, Kuramoto-cho, Tokushima 770-8503, Japan.

Funding

Japan Society for the Promotion of Science 22K15304
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Atractylodes lancea rhizomeBV-2exosome-like nanoparticleingenuity pathway analysismicroglianeuroinflammationnitric oxideRNA sequencingToll-like receptor 4

Identifiers

PMID40872491
PMCPMC12389435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.